Clinical Applications of Tumor Volume Measurements for Predicting Outcome in Patients with Squamous Cell Carcinoma of the Upper Aerodigestive Tract

References

1. ↵
   Isaacs JH, Manucso AA, Mendenhall WM. CT scanning as an aid to selection of therapy in T2–T4 laryngeal cancer. Head Neck Surg 1988;99:455–464
2. Mancuso AA, Hanafee WN. Larynx and hypopharynx. In: Computed Tomography and Magnetic Resonance Imaging of the Head and Neck. 2nd ed. Baltimore: Williams and Wilkins;1985 :241–357
3. ↵
   Curtin HD. Larynx. In: Som PM, Curtin HD, eds. Head and neck imaging. 3rd ed. St. Louis: Mosby–Year Book;1995 :612–707
4. ↵
   Fleming I, Cooper J, Henson D et al, eds. American Joint Committee on Cancer. Manual for Staging of Cancer. 5th ed. Philadelphia: Lippincott-Raven;1997
5. ↵
   Mancuso AA, Mukherji SK, Kotzur I, et al. Preradiotherapy-computed tomography as a predictor of local control in supraglottic carcinoma. J Clin Oncol 1999;17:631–636

   Abstract/FREE Full Text
6. ↵
   Hermans R, Van den Bogaert, Runders A, Baert A. Value of computed tomography as outcome predictor of supraglottic carcinoma treated by definitive radiation therapy. IJOBP 1999;44:755–765
7. ↵
   Chua DTT, Sham JST, Kwong DLW, et al. Volumetric analysis of tumor extent in nasopharyngeal carcinoma and correlation with treatment outcome. Int J Radiation Oncol Biol Phys 1997;39:711–719

   CrossRefPubMedWeb of Science
8. Johnson CR, Thames HD, Huang DT, Schmidt-Ullrich RK. The tumor volume and clonogen number relationship: tumor control predictions based upon tumor estimates derived from computed tomography. Int J Radiation Oncol Biol Phys 1995;33:281–287

   CrossRefPubMedWeb of Science
9. ↵
   Freeman DE, Mancuso AA, Parsons JT, et al. Irradiation alone for supraglottic larynx carcinoma: can CT findings predict treatment results? Int J Radiation Oncol Biol Phys 1990;19:485–490

   CrossRefPubMedWeb of Science
10. ↵
    Pameijer FA, Mancuso AA, Mendenhall WM, Parsons JT, Kubilis PS. Can pretreatment computed tomography predict local control in T3 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy? Int J Radiation Oncol Biol Phys 1997;37:1011–1021

    CrossRefPubMedWeb of Science
11. ↵
    Lee WR, Mancuso AA, Saleh EM, et al. Can pretreatment computed tomography findings predict local control in T3 squamous cell carcinomas of the glottic larynx treated with radiotherapy alone? Int J Radiation Oncol Biol Phys 1993;25:683–687

    PubMed
12. Gilbert RW, Birt D, Shulman H, et al. Correlation of tumor volume with local control in laryngeal carcinoma treated by radiotherapy. Ann Otol Rhinol Laryngol 1987;96:514–518

    PubMed
13. Mukherji SK, O’brien SM, Gerstle RJ, Castillo M. Tumor volume: an independent predictor of outcome for laryngeal cancer. JCAT 1999;23:50–54
14. ↵
    Mukherji SK, Gerstle RJ, O’brien SM, et al. Tumor volume as a predictor of local control in patients with laryngeal cancer treated surgically. J Hong Kong Coll Radiol 1999;2:104–111
15. ↵
    Hermans R, Van den Bogaert W, Rijnders A, Doornaert P, Baert A. Predicting the local control of glottic squamous cell carcinoma after definitive radiation therapy: value of computed tomography-determined tumour parameters. Radiother Oncol 1999;50:39–46

    CrossRefPubMed
16. ↵
    Mukherji SK, Gerstle RJ, O’brien SM, et al. The ability of tumor volume to predict local control in surgically treated squamous cell carcinoma of the supraglottic larynx. Head Neck 2000;22:282–287

    CrossRefPubMed
17. ↵
    Mukherji SK, Mancuso AA, Mendenhall M, O’brien S, Weissler M, Pillsbury HC. The ability of tumor volume to predict relative risks of local failure associated with surgical and non-surgical treatment of supraglottic carcinoma. Asian Oceanic J Radiol 2001;6:13–20
18. ↵
    Keberle M, Hoppe F, Dotzel S, Hahn D. Prognostic value of pretreatment CT regarding local control in oropharyngeal cancer after primary surgical resection. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 2002;175:61–66
19. Kurek R, Kalogera-Fountazila A, Muskalla K, et al. Usefulness of tumor volumetry as a prognostic factor of survival in head and neck cancer. Strhlenther Onkol 2003;179:292–297

    CrossRef
20. Doweck I, Denys D, Robbins KT. Tumor volume predicts outcome for advanced head and neck cancer treated with targeted chemotherapy. Laryngoscope 2002;112:1742–1749

    CrossRefPubMedWeb of Science
21. ↵
    Miller TR, Grigsby PW. Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated with radiation therapy. Int J Radiat Oncol Biol Phys 2002;53:353–359

    CrossRefPubMed
22. ↵
    Sanguinetti G, Foppiano F, Marcenaro M, et al. On the delineation of the gross tumor volume and the clinical target volume for head and neck squamous cell carcinomas. Tumori 2001;87:153–161

    PubMed
23. ↵
    Chang CC, Chen MK, Liu MT, Wu HK. The effect of primary tumor volumes in advanced t-staged nasopharyngeal tumors. Head Neck 2002;24:940–946

    CrossRefPubMedWeb of Science
24. ↵
    Chang CC, Chen MK, Liu MT, et al. Primary tumor volume delineation in nasopharyngeal carcinoma and correlation with 1997 AJCC tumor stage classification. J Otolaryngol 2001;30:231–234

    CrossRefPubMed
25. ↵
    Hermans R, Feron M, Bellon, Dupont P, Van Den Bogaert W, Baert AL. Laryngeal tumor volume measurements determined with CT: a study of intra- and interobserver variability. Int J Radiation Oncol Biol Phys 1998;40:553–557

    CrossRefPubMed
26. ↵
    Castelijns JA, van den Brekel MW, Tobi H, et al. Laryngeal carcinoma after radiation therapy: correlation of abnormal MR imaging signal patterns in laryngeal cartilage with the risk of recurrence. Radiology 1996;198:151–155

    PubMedWeb of Science
27. Castelijns JA, van den Brekel MW, Smit EM, et al. Predictive value of MR imaging-dependent and non-MR imaging-dependent parameters for recurrence of laryngeal cancer after radiation therapy. Radiology 1995;196:735–739

    PubMed
28. ↵
    Pameijer FA, Hermans R, Mancuso AA, et al. Pre- and post-radiotherapy computed tomography in laryngeal cancer: imaging-based prediction of local failure. Int J Radiat Oncol Biol Phys 1999;45:359–366

    PubMed
29. ↵
    Tart RP, Mukherji SK, Lee WR, Mancuso AA. Value of laryngeal cartilage sclerosis as a predictor of outcome in patients with stage T3 glottic cancer treated with radiation therapy. Radiology 1994;192:567–570

    PubMed
30. ↵
    Mukherji SK, Mancuso AA, Mendenhall W, Kotzur IM, Kubilis P. Can pretreatment CT predict local control of T2 glottic carcinomas treated with radiation therapy alone?
31. ↵
    Murakami R, Furusawa M, Baba Y, et al. Dynamic helical CT of T1 and T2 glottic carcinomas: predictive value for local control with radiation therapy. AJNR Am J Neuroradiol 2000;21:1320–1326

    Abstract/FREE Full Text
32. ↵
    Pameijer FA, Mancuso AA, Mendenhall WM, Parsons JT, Mukherji SK, Kubilis PS. Evaluation of pretreatment computed tomography as a predictor of local control in T1/T2 pyriform sinus carcinoma treated with definitive radiotherapy. Head Neck 1998;20:159–168

    CrossRefPubMed
33. ↵
    Hermans R, Op De Beeck K, Van Den Bogaert W, et al. The relation of CT-determined tumor parameters and local and regional outcome of tonsillar cancer after definitive radiation therapy. IJROBP 2001;50:37–45
34. ↵
    Nathu R, Mancuso AA, Zhu TC, Mendenhall WM. The impact of primary tumor volume on local control for oropharyngeal squamous cell carcinoma treated with radiotherapy. Head Neck 2000;22:1–5

    CrossRefPubMed
35. ↵
    Fletcher GH, Hamberger AD. Causes of failure in irradiation of squamous cell carcinoma of the supraglottic larynx. Radiology 1974;111:697–700

    CrossRefPubMed
36. ↵
    Mukherji SK, Mancuso AA, Kotzur I, et al. Radiographic appearance of the irradiated larynx, I: expected changes. Radiology 1994;193:141–148

    PubMed
37. ↵
    Mukherji SK, Mancuso AA, Kotzur I, et al. Radiographic appearance of the irradiated larynx, II: primary site response. Radiology 1994;193:149–154

    PubMed
38. ↵
    Mukherji SK, Drane WE, Tart RP, Mancuso AA. Comparison of SPECT FDG and SPECT Thallium-201 for imaging of squamous cell carcinoma of the head and neck. AJNR Am J Neuroradiol 1994;15:1837–1842

    Abstract/FREE Full Text
39. Mukherji SK, Gapany M, Phillips D, et al. Squamous cell carcinoma of the upper aerodigestive tract: the ability of thallium-201 SPECT to detect recurrent tumor. AJNR Am J Neuroradiol 1999;20:1215–1220

    Abstract/FREE Full Text
40. Fischbein N, Anzai Y, Mukherji SK. Application of new imaging techniques for the evaluation of squamous cell carcinoma of the head and neck. Semin Ultrasound CT MR 1999;20:187–212

    CrossRefPubMed
41. Lapela M, Eigtved A, Jyrkkio S, et al. Experience in qualitative and quantitative FDG PET in follow-up of patients with suspected recurrence from head and neck cancer. Eur J Cancer 2000;36:858–867
42. Di Martino E, Nowak B, Hassam H, et al. Diagnosis and staging of head and neck cancer: a comparison of modern imaging modalities (positron emission tomography, computed tomography, color-coded duplex sonography) with panendoscopic and histopathologic findings. Arch Otolaryngol Head Neck Surg 2000;126:1457–1461

    PubMedWeb of Science
43. Anzai Y, Carroll WR, Quint DJ, et al. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2- [F-18] fluoro-D-glucose PET and MR imaging diagnoses. Radiology 1996;200:135–141

    PubMed
44. Bailet JW, Sercarz JA, Abemayor E, et al. The use of positron emission tomography for early detection of recurrent head and neck carcinoma in postradiotherapy patients. Laryngoscope 1995;105:135–139

    PubMedWeb of Science
45. Farber LA, Benard F, Machtay M, et al. Detection of recurrent head and neck squamous cell carcinoma after radiation therapy with 2–18F-fluoro-2-deoxy-D-glucose positron emission tomography. Laryngoscope 1999;109:970–975

    CrossRefPubMedWeb of Science
46. Fischbein NJ, Aassar OS, Caputo GR, et al. Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck. AJNR Am J Neuroradiol 1998;19:1189–1196

    Abstract
47. Greven KM, Williams DW III, Keyes JW Jr, et al. Distinguishing tumor recurrence from irradiation sequelae with positron emission tomography in patients treated for larynx cancer. Int J Radiat Oncol Biol Phys 1994;29:841–845

    CrossRefPubMed
48. Hanasono MM, Kunda LD, Segall GM, et al. Uses and limitations of FDG positron emission tomography in patients with head and neck cancer. Laryngoscope 1999;109:880–885

    CrossRefPubMedWeb of Science
49. Keyes JW Jr, Watson NE Jr, Williams DW III, et al. FDG PET in head and neck cancer. AJR Am J Roentgenol 1997;169:1663–1669

    CrossRefPubMedWeb of Science
50. Lapela M, Grenman R, Kurki T, et al. Head and neck cancer: detection of recurrence with PET and 2-[F-18] fluoro-2-deoxy-D-glucose. Radiology 1995;197:205–211

    PubMed
51. Manolidis S, Donald PJ, Valk P, Pounds TR. The use of positron emission tomography scanning in occult and recurrent head and neck cancer [Suppl]. Acta Otolaryngol (Stockh) 1998;534:1–11
52. Paulus P, Sambon A, Vivegnis D, et al. 18FDG PET for the assessment of primary head and neck tumors: clinical, computed tomography, and histopathological correlation in 38 patients. Laryngoscope 1998;108:1578–1583

    CrossRefPubMedWeb of Science
53. Rege S, Maass A, Chaiken L, et al. Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancer. Cancer 1994;73:3047–3058

    CrossRefPubMedWeb of Science
54. Stokkel MPM, Terhaard CHJ, Hordijk GJ, van Rijk PP. The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography. Eur J Nucl Med 1999;26:767–773

    CrossRefPubMed
55. Nowak B, DiMartino E, Janicke S, et al. Diagnostic evaluation of malignant head and neck cancer by F-18-FDG PET compared to CT/MRI. Nuklearmedizin 1999;38:312–318

    PubMed
56. Li P, Zhuang H, Mozley PD, et al. Evlauation of recurrent squamous cell carcinoma of the head and neck with FDG positron emission tomography. Clin Nucl Med 2001;26:131–135

    CrossRefPubMed
57. Nagamachi S, Jinnouchi S, Flores LG, et al. The use of Tl-201 SPECT to predict the response to radiotherapy in patients with head and neck cancer. Nucl Med Comm 1996;17:935–942

    PubMed
58. ↵
    Gregor T, Valdes-Olmes RA, Koops W, et al. Preliminary experience with thallous chloride Tl 201-labeled single photon emission computed tomography scanning in head and neck cancer. Arch Otolaryngol Head Neck Surg 1996;122:509–514

    CrossRefPubMedWeb of Science
59. ↵
    Labadie RF, Yarborough WG, Weissler MC, Pillsbury HC, Mukherji SK. Nodal volume reduction after concurrent chemo- and radiotherapy: correlation between initial CT and histologic findings. AJNR Am J Neuroradiol 2000;21:310–314

    Abstract/FREE Full Text